Revance Therapeutics Inc (RVNC)

[Mufaso]

Agreed that therapeutics is a major market. While CD is significant, it is not as large as the spasticity indication and the jury is out as to whether the spasticity indication will get off label Daxxi use of consequence.

However, Once Daxxi gets approved as a therapeutic, I expect the Cervical Dystonia info you posted will be "legitimized" and make it into sales conversations in the aesthetic space. This will help aesthetic sales grow.